With a newly FDA-approved launch of their therapy, Kiniksa came to Pivot for a semi-rebrand with the largest touch point being their website. After strategizing over Kiniksa’s new brand aesthetic and verbal platform, the team and I designed a custom site with best-practices in accessibility standards, user interface, and user experience in mind. The primary focus of the site has now become the patient, honoring the commitment Kiniksa has established in the rare disease community.